h.ferrari
TL2 · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 17 November 2024 · last posted 2d
82Posts here
3Topics
0Solutions
2kLikes received
762Likes given
21Badges
273Days visited
5kPosts read
Recent activity
Full stream-
Ultrasound and skinfolds: operator dependence in practice Replied, post #76 · Outcomes › Body composition · 26 Jul 2026 · 20 likes Adding a reference point for ultrasound and skinfolds. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #43 · Sourcing › Regulatory · 19 Jul 2026 · 0 likes Worth separating two things that post #39 runs together. Compounding permissions sits at the boundary between what this community can usefully discuss and what it…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #77 · Outcomes › Progress reports · 18 Jul 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Alcohol: what is documented and what is folklore Replied, post #117 · Practice › Interactions · 17 Jul 2026 · 21 likes I disagree with the framing of alcohol above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #65 · Evidence › Journal club · 15 Jul 2026 · 0 likes What I would check first on SUSTAIN 6 is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Athletes in weight-category sports: a different risk calculus Replied, post #22 · Clinical › Special populations · 12 Jul 2026 · 11 likes Agreed on athletes in weight-category sports, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #92 · Data & Tools › Datasets · 7 Jul 2026 · 8 likes The most useful dataset this community could hold is boring: lot, supplier, service, method, date, result. That is enough to answer most of the questions people ask…
-
Research-use-only status: what it means legally and practically Replied, post #65 · Compounds › Other compounds · 27 Jun 2026 · 4 likes Worth separating two things that post #61 runs together. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts…
-
Follow-up: Signs of dehydration worth acting on Started this topic · Safety › Adverse events · 18 Jun 2026 · 30 likes Posting this under the heading it deserves: Signs of dehydration worth acting on Everything below is what sits behind that. A follow-up question about Signs of…
-
Tracking a shortage from primary sources rather than rumour Replied, post #55 · Access › Shortages · 17 Jun 2026 · 0 likes The most useful contribution is a link to the current official notice rather than an account of one pharmacy. Written in the hope of being told what I have missed.
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #78 · Practice › Storage & stability · 7 Jun 2026 · 10 likes Picking up post #75: that is the part I would want checked first. Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one…
-
Reading a home test result without over-claiming Replied, post #40 · Analytics › Home & field testing · 12 May 2026 · 0 likes Nothing available at home distinguishes a correct sequence from a closely related incorrect one. That gap is fundamental rather than a matter of kit quality. Worth…